Oridonin exerts its anti-cancer activity by inducing mitochondria-mediated apoptosis through augmentation of Bax/Bcl-2 ratio, and activation of caspase–3 and 9, accompanied by augmented reactive oxygen species (ROS) production. Here, BAX is linked to cancer.